Australia Healthcare Diagnostics Market Sample Report 2022 to 2030

1. A sample report on Australia Healthcare Diagnostics Market Analysis

2. This report presents a strategic analysis of the Australia Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Australia Healthcare Diagnostics Market, and offers unmatched value, accuracy, and expert insights.

3. Report Scope Click on the icon to know the detailed methodology

4. Table of Content

5. Table of Content

6. Table of Content

7. Table of Content

8. 1. Healthcare Diagnostics Overview

9. 1.1 Statistics at a Glance: Status of Healthcare Diagnostics in the World Overview of Healthcare Diagnostics • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest $76.2 Bn Was the market size of Global Clinical Diagnostics in 2022 8.56% Can be the exhibiting CAGR of the Clinical Diagnostics Market from 2022-2028 17-20% Is the expected increase in revenue of the diagnostic companies 55% Of the most downloaded clinically rated apps are linked to biosensors $7 Bn/year Is the amount saved using the health apps by monitoring and diagnosing health condition associated with diabetes prevention and care, asthma, and cardiac and pulmonary rehabilitation Illustrative

10. 1.1 Statistics at a Glance: The Status of Healthcare Diagnostics in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR Australia Market ~$xx Mn Market Africa ~Market Size of $XX Bn Illustrative

11. 1.2 Australia Overview • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest 25.7 Mn Is the population of Australia, in 2021 $1.55 Tn Is the Gross Domestic Product (GDP) in Australia in 2021 38.5 years Is the median age in Australia, in 2022 $8617 per capita was the amount of national health expenditures in 2021 Illustrative

12. 1.3 Economic Overview: Australia Population of Australia, (2020-2030) GDP of Australia, (2020-2030) Population Split (2023) • In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest By Gender By Age Group 0-14 15-24 25-54 55-64 65+ Illustrative

13. 1.4 Statistics at a Glance: Glance at Australia Healthcare Diagnostics Market • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Australia • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest $827 Mn Was the market size of Australia Clinical Diagnostics Market in 2022 7.5% Is the expected CAGR of the Australia Clinical Diagnostics Market for period of 2022-2030 2,808 Is the number of medical and diagnostic laboratory companies are present in Australia 42 days Is the average waiting period for CT scans in Australia Illustrative

14. 1.5 Healthcare Services in Australia • Australia Healthcare Services Market Forecast, 2022-2030 (in $Bn) • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the overall Healthcare Services market in Australia, which includes the market size, current trends and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

15. 1.6 Healthcare Scenario in Australia • Healthcare scenario in Australia is characterized by a robust system that aims to provide universal access to high-quality healthcare services Universal Healthcare: Australia has a universal healthcare system known as Public. It provides Australians with access to subsidized medical services, including visits to general practitioners, specialist consultations, and public hospital services. Primary Healthcare: Primary healthcare plays a vital role in Australia's healthcare system. It involves general practitioners (GPs) who serve as patients’ first point of contact. GPs provide preventive care, diagnose and treat common illnesses, and refer patients to specialists when needed. Public and Private Healthcare: Australia has a mix of public and private healthcare sectors. Public hospitals are funded by the government and provide free or low-cost services to eligible patients. Private healthcare offers additional services and options for those who have private health insurance. Pharmaceutical Benefits Scheme (PBS): The PBS subsidizes the cost of prescription medications, making them more affordable for Australians. Under this scheme, patients pay a reduced price for medications listed on the PBS schedule. Aged Care Services: Australia has a well-developed aged care sector to cater to the needs of older adults. It includes residential aged care facilities, home care services, and community-based programs. Health Workforce: Australia has a well-trained and diverse healthcare workforce, including doctors, nurses, allied health professionals, and specialists. The country also welcomes international healthcare professionals to address workforce needs. Illustrative

16. 1.6 Healthcare Scenario in Australia (continued) • Healthcare scenario in Australia is characterized by a robust system that aims to provide universal access to high-quality healthcare services Health Promotion and Prevention: Australia emphasizes health promotion and disease prevention initiatives. Various campaigns and programs focus on promoting healthy lifestyles, disease screening, immunization, and early intervention. Digital Health: The adoption of digital health technologies is increasing in Australia. Electronic health records, telehealth services, and digital health platforms are being used to improve access to healthcare and enhance coordination of care. Illustrative

17. 1.6 Healthcare Scenario: Diagnostic Process Patient Journey Patient sees family doctor or specialist Results get sent to pathologist/ radiologist for review and analysis Physician sends patient for medical imaging Patient Laboratory Test/Imaging Test/Molecular Diagnostic Next StepBased on the radiologist's report, the referring physician decides on the next steps for patient Pathologist/Radiologist Report contains summary of findings, possible diagnoses, and recommended next steps Pathologist/Radiologist produces a report and sends it to referring physician Physician Illustrative

18. 1.7 Health Insurance Coverage: Australia % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage • In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year • More people had private health insurance (66%) than public coverage (35.7%) • Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) Illustrative

19. 1.8 Budget of Australia Government for Public Insurance • National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) • Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE • Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE • Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE • Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE • Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE • Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 • Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 • Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 • Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% Illustrative

20. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) Strategic Buyers Financial Buyers $100+ $50-$100 $25-$50 $0- $25 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative

21. 1.9 Mergers and Acquisitions (continued) Latest Deals In Australia Illustrative

22. 1.9 Mergers and Acquisitions (continued) Latest Deals In Australia Illustrative

23. 2. Market Size and Forecasting

24. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption • Australia Healthcare Diagnostics Market Forecast, 2022-2030(in $Bn) • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the overall Healthcare Insurance market in Australia, which includes the market size, current trends and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest CAGR~ XX% Illustrative

25. 2.2 Snapshot of Healthcare Diagnostics Market Segmentation By Test By Testing Methods By End-User Lipid Panel Laboratory Patients Liver Panel Imaging Healthcare Providers Renal Panel Point-of-care Clinical Laboratory Complete Blood Count Hospital & Healthcare institution Electrolyte Testing Others Infectious Disease Testing Others • In this section you will get an understanding of the segmentations which will cover the Australia Healthcare Diagnostics Market • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative

26. 2.2.1 Market Segmentation: By Test Australia Healthcare Diagnostics Market Share, By Test (2022) • Lipid Panel market in Australia is a significant component of the overall clinical diagnostics treatment market • It has the maximum market share in Australia clinical diagnostics market with approximately xx% • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

27. 2.2.2 Market Segmentation: By Product Australia Healthcare Diagnostics Market Share, By Testing Methods (2022) • Instruments clinical diagnostics market in Australia is a significant component of the overall clinical diagnostics market • It has the maximum market share in Australia clinical diagnostics market with approximately xx% • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

28. 2.2.3 Market Segmentation: By End User Australia Healthcare Diagnostics Market Share, By End User (2022) • Hospital Laboratories have the maximum market share in Australia clinical diagnostics market with approximately xx% • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

29. 3. Types of Healthcare Diagnostics Testing Methods

30. 3.1 Laboratory Test Top most commonly ordered laboratory tests in Australia Community Inpatient Emergency The data presented here includes over 51 commonly ordered laboratory tests by percentage in Australia (Appendix 3) Illustrative

31. 3.2 Imaging Test • Imaging tests in Australia include: X-rays, CT (Computed Tomography) scans, MRI (Magnetic Resonance Imaging) scans Ultrasound, PET (Positron Emission Tomography) scans, Nuclear imaging & Mammogram • In 2022, it was estimated that 28,600 Canadian women will be diagnosed with breast cancer ultimately raising the demand for Mammography Imaging as well as services • In August 2022, through a collaboration with Synthesis Health, Pelican Narrows and two additional Peter Ballantyne Cree Nation (PBCN) towns, Deschambault Lake and Southend, the first ultra portable X-ray equipment was installed in Australia Number of diagnostics expected to be performed in Australia (in Mn) Illustrative

32. 3.3 Point-Of-Care Testing POC Diagnostics Market Share, By Indication Key Insights • Increased prevalence of diabetes and cancer, the use of novel point-of-care diagnostics, and the preference for at-home glucose testing all contribute to the expansion of the blood glucose monitoring market • XX% of the population of Australia, or more than XX Mn people, have diabetes, and after accounting for population ageing over time, the prevalence has been rising at an average rate of XX% each year • Considerable risk of acquiring type 2 diabetes is also posed by the XX% prevalence of prediabetes in Canadian adults • On the other side, the category for infectious disorders is expected to develop at the quickest rate • Market segment for infectious diseases is anticipated to expand significantly over the forecast period due to the rising prevalence of various infectious disorders Other*- Hyperthyroidism, Oxygen Testing, assessment for developing contrast-induced nephropathy (CIN), Colorectal cancer screening, Dipstick urinalysis Illustrative

33. 4. Market Dynamics

34. 4.1 Market growth drivers 4.1.1 Increasing Prevalence of Health Morbidities like Cancer, Chronic & Infectious Diseases. 46.6% of population have at least 1 of 10 common chronic conditions in Australia Incidence of Diseases in Australia • Incidence of diseases is increasing in Australia, In 2021, approximately 151,000 new instances of cancer were identified in Australia. • Nearly half of Australians, spanning all age groups (46.6%), experienced one or more chronic conditions, with nearly one in five individuals (18.6%) grappling with two or more chronic health issues. • This is driving the demand for clinical diagnostics treatments and creating opportunities for growth in the clinical diagnostics market • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest xx% Illustrative

35. 4.1 Market growth drivers (continued) 4.1.2 Growing awareness about early detection & screening of diseases. The Australian government has established nationwide screening initiatives for breast, cervical, and bowel cancers Top countries that are leveraging technology in their fight against healthcare diagnostics • Primary goal of these screening programs is to enhance public health outcomes by minimizing the impact of illness and mortality associated with these cancers through early detection and timely intervention • QAAMS pathology program is designed to offer prompt on-site diabetes testing specifically for Aboriginal and Torres Strait Islander individuals residing in rural and remote areas • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

36. 4.1 Market growth drivers (continued) 4.1.3 Government initiatives and investments in increasing number and quality of equipment in diagnostic facility. Fundings from government and other organizations • Australia government provides significant support and funding for clinical diagnostics research and treatment, which is driving innovation and growth in the clinical diagnostics market • Albanese Government is allocating $XX Mnto support XX projects focused on providing educational initiatives for healthcare professionals and the public • These programs aim to enhance awareness about the appropriate utilization of medicines and diagnostic technologies • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative

37. 4.2 Market restraints 3.2.3 Data Privacy Concerns. Approximately 75% of Australians believe that data breaches pose one of the most significant privacy threats they encounter in the present day 3.2.2 Australia's clinical diagnostics sector operates under rigorous regulations, featuring strict standards for the approval of products and ongoing quality monitoring 3.2.1 High cost & Delayed in Diagnosis. 30% of Australian children with rare disease waited for 5 or more years for diagnosis • Medicare breach reported in October 2022 was among the most recent incidents that profoundly impacted the industry, revealing the sensitive data of 9.7 Mn existing and former customers • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest • Clinical diagnostics treatments can be very expensive and can lead to financial burden for patients and healthcare systems • Cost of clinical diagnostics treatment varies depending on the type of clinical diagnostics, stage of clinical diagnostics, and treatment options • Some common clinical diagnostics treatments, such as chemotherapy and radiation therapy, can cost tens of thousands of dollars • Requirements for clinical diagnostics treatments can be very stringent, which can slow down the approval process and limit access to new treatments • Therapeutic Goods Administration (TGA) is the regulatory authority overseeing medical devices, including in vitro diagnostic medical devices, in Australia • Manufacturers and sponsors of medical devices are obligated to adhere to the mandatory requirements and fulfill ongoing responsibilities as stipulated by the TGA Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative

38. 5. Competitive Landscape

39. 5.1 Key Company Profile Service Providers Manufacturers Key Note: 1 • Here is the list of top 10 companies which will cover in the final report • Each company will have slides for • Overview • Key details • Offerings • Name of products • Recent activities/ Press Coverage • Distribution and Vendor Partners • Mergers, Acquisitions and Collaboration • Financials • If there are specific companies that you would like to be included in the report, please let us know via email • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Australian Clinical Labs 6 AusDiagnostics 2 Healius Healthcare 7 Abbott 3 Sonic Healthcare 8 Bio-Rad Laboratories, Inc 4 Austech Medical Laboratories 9 Roche 5 Healthcscope Limited 10 Siemens Illustrative

40. 5.1.1 Australian Clinical Labs (ACL) Founded in: 2015 HQ: Sydney, Australia Type: Private Revenue: $995.6 Mn Website: Australian Clinical Labs • Australian Clinical Labs stands as a prominent private pathology services provider in Australia, with 75 laboratories accredited by NATA, offering essential diagnostic services • Annually, our accredited laboratories conduct more than 12 million tests, benefiting both healthcare professionals and individuals within the local communities we serve • As a leading entity in the field, Australian Clinical Labs plays a vital role in delivering high-quality pathology services to clinicians and patients across Australia Services Offered Recent Activity / Press Coverage Illustrative

41. 5.1.1 Australian Clinical Labs(continued) Subsidiaries Major Divisions Major Brands Illustrative

42. 5.1.1 Australian Clinical Labs(continued) Important Deals - Mergers and Acquisitions Illustrative

43. 5.1.1 Australian Clinical Labs(continued) Revenues ($Bn), 2020-2030 • $977.9 Mn was the revenue generated by Australian Clinical Labs in 2022 • They are profitable in a wide range of laboratory testing services including routine and specialty tests in areas such as hematology, clinical chemistry, immunology, molecular diagnostics and genetics • Revenue generated by Dynacare in 2020 reflects the company's continued growth and success in the healthcare industry • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Breakdown of Net Revenue by Segment, 2022 Illustrative

44. 5.1.2 Company 2 Founded in: HQ: Type: Revenue: Website: Drugs for clinical diagnostics Recent Activity / Press Coverage Illustrative

45. 5.1.2 Company 2 (continued) Partnerships Ecosystem Major Vendor Partners Major Distribution Partners Illustrative

46. 5.1.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Illustrative

47. 5.1.2 Company 2 (continued) Revenues ($Bn), 2020-2030 • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Breakdown of Net Revenue by Segment, 2022 Illustrative

48. 6. Reimbursement Scenario

49. 6.1 Reimbursement Regulation Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Australians • The reimbursement scenario in the Australia HealthcareDiagnosticsMarket is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: • Medicare: • Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions • Medicare covers many clinical diagnostics treatments, including chemotherapy, radiation therapy, and some immunotherapies • However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization • Medicaid: • Medicaid is a joint federal-state program that provides health insurance for people with low incomes • Medicaid coverage for clinical diagnostics treatments can vary by state, and may be subject to limits on the amount and type of treatment covered • Private Insurance: • Private insurance coverage for clinical diagnostics treatments can also vary widely depending on the insurer and the specific policy • Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Health Insurance Coverage, 2022 Illustrative

50. 6.1 Reimbursement Regulation (continued) • Affordable Care Act: • Affordable Care Act (ACA) includes provisions to help improve access to clinical diagnostics treatments by requiring insurers to cover certain preventive services, including clinical diagnostics screenings, without co-pays or deductibles • It also includes protections for people with pre-existing conditions, such as clinical diagnostics • Reimbursement for New Treatments: • Reimbursement for new clinical diagnostics treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage • This can create challenges for companies developing and marketing new treatments • Value-Based Care: • There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments • Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative